Soft tissue fillers used for facial rejuvenation can cause complications. We present two cases of late migration of injected fillers mimicking other pathology in the periocular area. Case 1 is a 52-year-old woman referred with chronic bilateral upper lid swelling, mimicking blepharochalasis syndrome, 51/2 years after undergoing injection of hyaluronic acid filler in both brows. Extensive blood investigations were normal. Bilateral, sequential upper lid biopsy revealed migrated hyaluronic acid filler, which was successfully treated with hyaluronidase. Case 2 is a 62-year-old woman who presented with a right lower lid mass 8 years after undergoing injection of polyalkylimide gel into both cheeks. CT scanning confirmed an intermediate density soft tissue mass overlying the inferior orbital rim. Histology from surgical excision reported chronic granulomatous inflammation due to migrated polyalkylimide gel. An awareness of late migration of fillers causing eyelid swelling and masses in the periocular area will prevent unnecessary investigations and facilitate prompt management.

Clinical Neuroscience Addenbrooke's Hospital Cambridge UK

Histopathology Addenbrooke's Hospital Cambridge UK

Ophthalmology Addenbrooke's Hospital Cambridge UK

Zobrazit více v PubMed

Dermal Fillers Market Size, Growth & Revenue Analysis [2020-2027]. Available: https://www.fortunebusinessinsights.com/industry-reports/dermal-fillers-market-100939 [Accessed 14 Feb 2021].

Jordan DR, Stoica B. Filler migration: a number of mechanisms to consider. Ophthalmic Plast Reconstr Surg 2015;31:257–62. 10.1097/IOP.0000000000000368 PubMed DOI

Chiang YZ, Pierone G, Al-Niaimi F. Dermal fillers: pathophysiology, prevention and treatment of complications. J Eur Acad Dermatol Venereol 2017;31:405–13. 10.1111/jdv.13977 PubMed DOI

Alsuhaibani AH, Alfawaz N. Lower eyelid swelling as a late complication of Bio-Alcamid filler into the malar area. Saudi J Ophthalmol 2011;25:75–9. 10.1016/j.sjopt.2010.10.006 PubMed DOI PMC

Vasquez RAS, Park K, Braunlich K, et al. . Prolonged Periorbicular edema after injection of hyaluronic acid for Nasojugal groove correction. J Clin Aesthet Dermatol 2019;12:32–5. PubMed PMC

Chang JR, Baharestani S, Salek SS, et al. . Delayed superficial migration of retained hyaluronic acid years following periocular injection. Ophthalmic Plast Reconstr Surg 2017;33:S116–8. 10.1097/IOP.0000000000000434 PubMed DOI

Khan TT, Woodward JA. Retained dermal filler in the upper eyelid masquerading as periorbital edema. Dermatol Surg 2015;41:1182–4. 10.1097/DSS.0000000000000442 PubMed DOI

Yu JTS, Peng L, Ataullah S. Chronic eyelid edema following periocular hyaluronic acid filler treatment. Ophthalmic Plast Reconstr Surg 2017;33:e139–40. 10.1097/IOP.0000000000000871 PubMed DOI

Lee DW, Park ES, Lee WS, et al. . Upper eyelid pseudocyst related to forehead filler migration: a rare complication of an illegal filler injection. Arch Aesthetic Plast Surg 2017;23:87–91. 10.14730/aaps.2017.23.2.87 DOI

Nathoo NA, Rasmussen S, Dolman PJ, et al. . Periocular mass lesions secondary to dermatologic fillers: report of 3 cases. Can J Ophthalmol 2014;49:468–72. 10.1016/j.jcjo.2014.07.004 PubMed DOI

Mosleh R, Mukari A, Krausz J, et al. . Orbit mass secondary to migration of dermal hyaluronic acid filler. JAAD Case Rep 2019;5:488–90. 10.1016/j.jdcr.2019.03.002 PubMed DOI PMC

Hamed-Azzam S, Burkat C, Mukari A, et al. . Filler migration to the orbit. Aesthet Surg J 2020. 10.1093/asj/sjaa264. [Epub ahead of print: 05 Sep 2020]. PubMed DOI

AlHarbi ZA, Alkatan HM, Alsuhaibani AH. Long-Term outcomes of surgically removed migrated polyalkylimide (bio-alcamid) filler to the periorbital area. Saudi J Ophthalmol 2019;33:251–4. 10.1016/j.sjopt.2019.06.001 PubMed DOI PMC

Malik S, Mehta P, Adesanya O, et al. . Migrated periocular filler masquerading as arteriovenous malformation: a diagnostic and therapeutic dilemma. Ophthalmic Plast Reconstr Surg 2013;29:e18–20. 10.1097/IOP.0b013e31825b34db PubMed DOI

Hönig JF, Brink U, Korabiowska M. Severe granulomatous allergic tissue reaction after hyaluronic acid injection in the treatment of facial lines and its surgical correction. J Craniofac Surg 2003;14:197–200. 10.1097/00001665-200303000-00011 PubMed DOI

Cecchi R, Spota A, Frati P, et al. . Migrating granulomatous chronic reaction from hyaluronic acid skin filler (Restylane): review and histopathological study with histochemical stainings. Dermatology 2014;228:14–17. 10.1159/000356421 PubMed DOI

Alijotas-Reig J, Fernández-Figueras MT, Puig L. Pseudocystic encapsulation: a late noninflammatory complication of hyaluronic acid filler injections. Dermatol Surg 2013;39:1726–8. 10.1111/dsu.12316 PubMed DOI

Kopp S, Lawrence N, Donofrio L, et al. . Delayed migration of hyaluronic acid fillers: a new complication? Dermatol Surg 2014;40:85–7. 10.1111/dsu.12379 PubMed DOI

Lazzeri D, Agostini T, Figus M, et al. . Blindness following cosmetic injections of the face. Plast Reconstr Surg 2012;129:995–1012. 10.1097/PRS.0b013e3182442363 PubMed DOI

Bae IH, Kim MS, Choi H, et al. . Ischemic oculomotor nerve palsy due to hyaluronic acid filler injection. J Cosmet Dermatol 2018;17:1016–8. 10.1111/jocd.12498 PubMed DOI

Kwon SG, Hong JW, Roh TS, et al. . Ischemic oculomotor nerve palsy and skin necrosis caused by vascular embolization after hyaluronic acid filler injection: a case report. Ann Plast Surg 2013;71:333–4. 10.1097/SAP.0b013e31824f21da PubMed DOI

da Costa A, Biccigo DGZ, de Souza Weimann ET, et al. . Durability of three different types of hyaluronic acid Fillers in skin: are there differences among biphasic, monophasic Monodensified, and monophasic Polydensified products? Aesthet Surg J 2017;37:573–81. 10.1093/asj/sjw161 PubMed DOI

Ballin AC, Cazzaniga A, Brandt FS. Long-Term efficacy, safety and durability of Juvéderm® XC. Clin Cosmet Investig Dermatol 2013;6:183–9. 10.2147/CCID.S33568 PubMed DOI PMC

Pacini S, Ruggiero M, Morucci G, et al. . Bio-alcamid: a novelty for reconstructive and cosmetic surgery. Ital J Anat Embryol 2002;107:209–14. PubMed

Ross AH, Malhotra R. Long-term orbitofacial complications of polyalkylimide 4% (bio-alcamid). Ophthalmic Plast Reconstr Surg 2009;25:394–7. 10.1097/IOP.0b013e3181b3ac71 PubMed DOI

Schelke LW, Velthuis PJ, van Dijk MR. Polyalkylimide: a Nonstable filler over time. Dermatol Surg 2018;44:563–7. 10.1097/DSS.0000000000001388 PubMed DOI